biostudies-literatureBarlow WEPROSPRNCINational Cancer InstituteNCI NIH HHS238-246https://www.ebi.ac.uk/biostudies/studies/S-EPMC7073922biostudies-literatureUnknown112(3)<h4>Background</h4>Cancer screening is a complex process encompassing risk assessment, the initial screening examination, diagnostic evaluation, and treatment of cancer precursors or early cancers. Metrics that enable comparisons across different screening targets are needed. We present population-based screening metrics for breast, cervical, and colorectal cancers for nine sites participating in the Population-based Research Optimizing Screening through Personalized Regimens consortium.<h4>Methods</h4>We describe how selected metrics map to a trans-organ conceptual model of the screening process. For each cancer type, we calculated calendar year 2013 metrics for the screen-eligible target population (breast: ages 40-74 years; cervical: ages 21-64 years; colorectal: ages 50-75 years). MetrJournal of the National Cancer InstituteEvaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.PMC7073922U01CA163304U54CA163307U54CA163308P30 CA008748U54CA163313U54CA164336U54CA163303U54 CA163308U54 CA163307U54CA163308-04S1U54 CA163303U54CA163261U54CA163262U54 CA163313U54 CA164336U54CA163261-04S1P30 CA016086U54 CA163262U54 CA163261U01 CA163304U54CA163262-04S1Doubeni CAArmstrong KBeaber EFDoria-Rose VPCorley DABalasubramanian BAHalm EASchapira MMKobrin SOnega TBarlow WEChubak JSkinner CSMcLerran DSprague BLKamineni ASilverberg MJWheeler CMGeller BMZheng YTosteson ANARutter CMHaas JSWeaver DLQuinn VPTiro JASchnall MDZauber AGChao CRfalseEvaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.<h4>Background</h4>Cancer screening is a complex process encompassing risk assessment, the initial screening examination, diagnostic evaluation, and treatment of cancer precursors or early cancers. Metrics that enable comparisons across different screening targets are needed. We present population-based screening metrics for breast, cervical, and colorectal cancers for nine sites participating in the Population-based Research Optimizing Screening through Personalized Regimens consortium.<h4>Methods</h4>We describe how selected metrics map to a trans-organ conceptual model of the screening process. For each cancer type, we calculated calendar year 2013 metrics for the screen-eligible target population (breast: ages 40-74 years; cervical: ages 21-64 years; colorectal: ages 50-75 years). Metr2020-01-01T00:00:00Z2020 Mar2025-04-21T20:11:02.321Z2025-04-05T17:53:32.486ZS-EPMC70739223129263310.1093/jnci/djz137